featured
Neutrophil to Lymphocyte Ratio for Predicting Outcomes in Patients With DPP-4 Inhibitor–Associated Bullous Pemphigoid
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Neutrophil to Lymphocyte Ratio Is Predictive of Severe Complications and Mortality in Patients With Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid: A Retrospective Longitudinal Observational Study
J Am Acad Dermatol 2021 May 28;[EPub Ahead of Print], S Sugiyama, T Yamamoto, Y AoyamaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.